These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
163 related articles for article (PubMed ID: 8834657)
21. [Effect of recombinant human erythropoietin on the bone marrow picture in patients with chronic renal failure treated by hemodialysis]. Sułowicz W; Hanicki Z; Skotnicki AB; Wójcik J; Sydor A Przegl Lek; 1992; 49(3):88-90. PubMed ID: 1438902 [TBL] [Abstract][Full Text] [Related]
22. The comparison of insulin sensitivity in non-diabetic hemodialysis patients treated with and without recombinant human erythropoietin. Tuzcu A; Bahceci M; Yilmaz E; Bahceci S; Tuzcu S Horm Metab Res; 2004 Oct; 36(10):716-20. PubMed ID: 15523598 [TBL] [Abstract][Full Text] [Related]
23. [Hemostatic changes associated with recombinant human erythropoietin (rHu Epo) treatment]. Vinhas J; Assis P; Oliveira C; Crespo F; Prata MM Acta Med Port; 1991; 4(1):9-12. PubMed ID: 2048426 [TBL] [Abstract][Full Text] [Related]
24. [The effect of long term erythropoietin treatment on levels of free amino acids in patients with long term hemodialysis]. Boratyńska M; Boratyński J; Magott M; Szewczyk Z Przegl Lek; 1996; 53(5):398-401. PubMed ID: 8754400 [TBL] [Abstract][Full Text] [Related]
25. Influence of long-term erythropoietin treatment on plasma levels of calcium-phosphate related hormones in haemodialyzed uraemic patients. Kokot F; Wiecek A; Marcinkowski W; Schmidt-Gayk H; Rudka R; Trembecki J Ann Univ Mariae Curie Sklodowska Med; 1994; 48 Suppl 3():9-16. PubMed ID: 8192535 [TBL] [Abstract][Full Text] [Related]
26. Recombinant human erythropoietin for chronic renal failure anaemia in pre-dialysis patients. Cody J; Daly C; Campbell M; Donaldson C; Grant A; Khan I; Pennington S; Vale L; Wallace S; MacLeod A Cochrane Database Syst Rev; 2001; (4):CD003266. PubMed ID: 11687180 [TBL] [Abstract][Full Text] [Related]
27. The effect of i.v. iron alone or in combination with low-dose erythropoietin in the rapid correction of anemia of chronic renal failure in the predialysis period. Silverberg DS; Blum M; Agbaria Z; Deutsch V; Irony M; Schwartz D; Baruch R; Yachnin T; Steinbruch S; Iaina A Clin Nephrol; 2001 Mar; 55(3):212-9. PubMed ID: 11316241 [TBL] [Abstract][Full Text] [Related]
31. PAF-acetylhydrolase activity in plasma of patients with chronic kidney disease. Effect of long-term therapy with erythropoietin. Papavasiliou EC; Gouva C; Siamopoulos KC; Tselepis AD Nephrol Dial Transplant; 2006 May; 21(5):1270-7. PubMed ID: 16421163 [TBL] [Abstract][Full Text] [Related]
32. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis. Brandi L Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159 [TBL] [Abstract][Full Text] [Related]
33. Is folate supplementation necessary in hemodialysis patients on erythropoietin therapy. Ono K; Hisasue Y Clin Nephrol; 1992 Nov; 38(5):290-2. PubMed ID: 1451343 [TBL] [Abstract][Full Text] [Related]
34. The effect of high-flux hemodialysis on renal anemia. Ayli D; Ayli M; Azak A; Yüksel C; Kosmaz GP; Atilgan G; Dede F; Abayli E; Camlibel M J Nephrol; 2004; 17(5):701-6. PubMed ID: 15593038 [TBL] [Abstract][Full Text] [Related]
35. [Optimal therapy with erythropoietin (EPO) in patients with renal anemia on hemodialysis therapy]. Merta M; Sobotová D; Zahálková J; Bitterová Z; Jirka T; Knetl P; Kopenec J; Suchanová J; Vlasák J Sb Lek; 2001; 102(1):41-52. PubMed ID: 11830918 [TBL] [Abstract][Full Text] [Related]
36. [Treatment of anemia in patients after long term hemodialysis with human recombinant erythropoietin]. Boratyńska M; Mazanowska O; Szewczyk Z Pol Merkur Lekarski; 1996 Nov; 1(5):329-31. PubMed ID: 9273209 [TBL] [Abstract][Full Text] [Related]
37. Hypertension induced by recombinant human erythropoietin (rHU-EPO) can be prevented by indomethacin. Pathogenetic role of cytosolic calcium. Schiffl H; Lang SM Eur J Med Res; 1997 Mar; 2(3):97-100. PubMed ID: 9113497 [TBL] [Abstract][Full Text] [Related]
38. Effect of intravenous ascorbic acid in hemodialysis patients with EPO-hyporesponsive anemia and hyperferritinemia. Attallah N; Osman-Malik Y; Frinak S; Besarab A Am J Kidney Dis; 2006 Apr; 47(4):644-54. PubMed ID: 16564942 [TBL] [Abstract][Full Text] [Related]
39. Long-term erythropoietin therapy does not affect metalloproteinases and their inhibitor levels, oxidative stress and inflammation in hemodialyzed patients. Pawlak K; Pawlak D; Mysliwiec M Am J Nephrol; 2007; 27(3):221-5. PubMed ID: 17384500 [TBL] [Abstract][Full Text] [Related]
40. Prospective controlled trial of a standardized meal stimulation test in the detection of pancreaticoduodenal endocrine tumours in patients with multiple endocrine neoplasia type 1. Langer P; Wild A; Celik I; Kopp I; Bergenfelz A; Bartsch DK Br J Surg; 2001 Oct; 88(10):1403-7. PubMed ID: 11578300 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]